MetLife Beats Appeal Over $65 Million Health Plan Drug Rebates

Sept. 25, 2024, 4:46 PM UTC

MetLife Group Inc. on Wednesday defeated a Third Circuit appeal by former employees who said the company mismanaged their health plan by improperly pocketing $65 million in drug rebates.

The MetLife employees didn’t show they’d suffered an injury establishing standing to sue, because there’s no indication they had an “individual right” to the rebate money they say was improperly withheld, the US Court of Appeals for the Third Circuit said.

It’s therefore only “speculative” that MetLife’s retention of this money caused them to pay more for their health insurance or had “any effect at all,” the court said in ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.